Everything you need to know about generic drug domains.

A generic drug name is already known independently of any individual pharmaceutical brand. The matching .com therefore creates a highly intuitive digital address for that molecule or active ingredient.

Depending on the company’s strategy, it can be used for:

• Product or therapeutic-area information
• Healthcare-professional or patient education
• Corporate or product-page redirects
• Search and content initiatives
• Market-specific campaigns
• Brand and digital-asset protection
• Future projects related to the molecule

Premium domains are unique assets, so there is no single formula that determines their value.

We consider factors such as the commercial significance of the underlying drug, global recognition of the generic name, search demand, domain age, the strength of the .com extension, comparable domain sales, potential uses and the strategic relevance of the name to pharmaceutical companies operating in that market.

Automated appraisal tools can provide an additional data point, but we do not consider an automated estimate alone to represent the strategic value of a premium pharmaceutical domain.

It depends on the domain. Some domains may have a firm asking price, while for others we may consider serious offers.

If you are interested in a specific domain, the best approach is to contact us with the domain name and your inquiry.

The process is straightforward. Once you have identified a domain you are interested in, contact us and we will confirm its availability and the applicable commercial terms.

Once both parties agree on the transaction, the purchase can be completed through an appropriate secure domain transaction or escrow process. The domain is then transferred to the buyer’s registrar account.

For corporate acquisitions, we can also coordinate with your legal, procurement, IT or domain-management team during the process.

Yes. For an agreed transaction, the transfer can be structured using a secure third-party transaction or escrow process appropriate to the sale.

This allows the payment and transfer of the domain to be coordinated in a way that protects both buyer and seller. For larger corporate transactions, additional documentation can be incorporated where required.

A domain can normally be transferred to the registrar selected by the buyer, subject to the applicable registrar and registry transfer rules.

Depending on where the domain is currently registered, the transfer may be completed either as an internal account push or as a registrar-to-registrar transfer using an authorization code.

We coordinate the transfer with the buyer until the domain is under the buyer’s control.

Digital Generics began building its pharmaceutical domain portfolio in 1998. Many of the domains have therefore been held for decades rather than being recently registered names.

Registration dates differ by domain, so if the age of a specific asset is important to your acquisition, contact us and we can provide the relevant details.

No. A domain name by itself does not guarantee search rankings.

Search performance depends on many factors including content quality, technical implementation, authority, links, user experience and the competitiveness of the search query.

An exact-match generic domain can nevertheless be a highly relevant and memorable foundation for a website focused on that specific pharmaceutical term.

Yes. A company does not have to build a standalone site immediately.

The domain can be held as a strategic digital asset or redirected to an existing corporate website, product page, therapeutic-area page or other relevant property. It can also be developed independently at a later stage.

Yes. Teva Pharmaceuticals acquired Olanzapine.com in November 2024 and subsequently began developing the website in 2025.

We have documented the project and its development in our Teva / Olanzapine.com case study .

Yes. We welcome inquiries involving multiple domains. This can be particularly relevant for pharmaceutical companies that manufacture or market several generic molecules and want to build or protect a broader portfolio of digital assets.

Send us the domains you are interested in and we can discuss them together.

We are open to discussing significant portfolio-level transactions with qualified buyers.

If you are considering an acquisition involving a large portion of the portfolio, please contact us directly with some background on your interest.

We aim to keep the portfolio current, but domain availability can change following a sale or pending transaction.

Please contact us before beginning an acquisition process and we will confirm current availability.

Yes. Start by searching our full domain portfolio .

If the generic drug or pharmaceutical term you are interested in does not appear there, contact us. We may be able to provide additional information or discuss related domain assets from the portfolio.

We are happy to speak with whoever is responsible for evaluating the asset. Depending on the organization, that may include teams working in:

• Digital strategy
• Marketing or brand management
• Commercial strategy
• Business development
• Corporate communications
• Domain-name management
• Legal or intellectual property
• Procurement

We can also provide information for internal review by multiple stakeholders.

The easiest way is through our contact page .

Mention the domain or domains you are interested in and, where relevant, your organization. We can then respond with the appropriate information for your inquiry.